-   								  								  								
Shares of Aimmune Therapeutics skyrocketed in extended trading Friday after the U.S. Food and Drug Administration approved the company's drug that reduces kids' allergic reactions to peanuts.   								More on this   							-   								
  									For more news, please go to FoxBusiness.com and watch Fox Business Network.   									   									    							   						   					 |   				
          
No comments:
Post a Comment